Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 Research Letter
| Authors: | Rapaport, F.; Seier, K.; Neelamraju, Y.; Hassane, D.; Baslan, T.; Gildea, D. T.; Haddox, S.; Lee, T.; Murdock, H. M.; Sheridan, C.; Thurmond, A.; Wang, L.; Carroll, M.; Cripe, L. D.; Fernandez, H.; Mason, C. E.; Paietta, E.; Roboz, G. J.; Sun, Z.; Tallman, M. S.; Zhang, Y.; Gönen, M.; Levine, R.; Melnick, A. M.; Kleppe, M.; Garrett-Bakelman, F. E. |
| Title: | Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 |
| Keywords: | adult; controlled study; survival rate; gene mutation; overall survival; somatic mutation; genetics; leukemia, myeloid, acute; clinical feature; antineoplastic agent; letter; gene; dna repair; cohort analysis; cytogenetics; cancer research; risk assessment; sex difference; karyotype; tet2 gene; clinical trial (topic); asxl1 gene; nucleophosmin; chromosome 16; clinical outcome; acute myeloid leukemia; recursive partitioning; humans; human; male; female; venetoclax; whole exome sequencing; srsf2 gene; u2af1 gene |
| Journal Title: | Blood Cancer Journal |
| Volume: | 12 |
| Issue: | 9 |
| ISSN: | 2044-5385 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2022-09-23 |
| Start Page: | 137 |
| Language: | English |
| DOI: | 10.1038/s41408-022-00736-z |
| PUBMED: | 36151075 |
| PROVIDER: | scopus |
| PMCID: | PMC9508258 |
| DOI/URL: | |
| Notes: | Letter -- Erratum issued, see DOI: 10.1038/s41408-023-00862-2 -- Export Date: 1 November 2022 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work